An interventional study of Repetitive transcranial magnetic stimulation (rTMS) and Treadmill training in Parkinson's Disease, sponsored by The Hong Kong Polytechnic University. Completed at 1 site in Hong Kong. Open to participants aged 40 Years to 70 Years. Per ClinicalTrials.gov, last updated 2019-11-22.
Sponsored by The Hong Kong Polytechnic University · Not applicable, Interventional, and Treatment
The purpose of this study is to investigate whether the beneficial effect of treadmill training on people with Parkinson's disease can be enhanced by high- and low-frequency repetitive transcranial magnetic stimulation (rTMS).
This is a randomised placebo-controlled trial. Fifty-one participants with Parkinson's disease (PD) will be recruited from the Hong Kong PD association, a self-help group and movement disorders clinic of 3 local hospitals. Written informed consent in accordance with the Declaration of Helsinki will be obtained from all participants. Eligible participants will be randomly assigned into one of the three groups: 1Hz-TT, 25Hz-TT, and sham-TT upon recruitment. Randomisation will be generated by a computer program and group assignment will be blinded to both participants and assessor. Participant will receive either 1-Hz, 25-Hz, or sham rTMS which will last for about 20 minutes followed by 30 minutes treadmill walking training for 12 sessions, 4 times per week for 3 weeks. All assessments will be conducted 1 week before intervention and 1 day after completion of intervention, after 1-month training and at 3-month post training.
The sample size calculation is based on the significant findings of the gait speed reported by Yang et al (2013). A two-way repeated measures ANOVA design with between-subject group effect (3 levels) and within-subject time effect (4 levels) determines that 15 subjects per group are required to achieve 85% power to test the interaction effect between groups and time effect with a 5% significance level and the effect size is 0.2. By assuming 10% dropout rate, 17 subjects will be required per group.
4,583 studies on the registry are indexed under Parkinson Disease; 1,097 are open to participants now.
This study's enrollment of 51 is above the median of 40 across 3,365 interventional studies indexed under Parkinson Disease.
Browse Parkinson Disease studies →The Hong Kong Polytechnic University is the lead sponsor of 676 studies on the registry; 254 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Participants will receive 4s train of 25-Hz rTMS pulses with 50s inter-train interval, with an intensity of 80% resting motor threshold (RMT). Participant will receive a total of 600 rTMS pulses in 6 minutes for each hemisphere and a total of 1200 pulses followed by 30 minutes of treadmill training.
Device: Repetitive transcranial magnetic stimulation (rTMS) · Other: Treadmill training
Participants will receive a total of 600 1-Hz rTMS pulses in 10 minutes for each hemisphere and a total of 1200 pulses ,with an intensity of 80% RMT, followed by 30 minutes of treadmill training.
Device: Repetitive transcranial magnetic stimulation (rTMS) · Other: Treadmill training
Sham rTMS will be applied over the same site as for real rTMS, however, with the cable of the coil disconnected. Another figure-of-eight coil using the same stimulation parameters (intensity, time, and frequency) as per 25Hz-TT group will be placed posterior to the subject's neck with the handle pointing backward to produce the same clicking sound effect. Sham rTMS will be followed by 30 minutes of treadmill training.
Device: Repetitive transcranial magnetic stimulation (rTMS) · Other: Treadmill training
Repetitive TMS (rTMS) is a painless and non-invasive technique for activation of cerebral cortex based on the principle of electromagnetic induction of an electric field in the brain. rTMS will be delivered to the scalp over the leg area of the bilateral motor cortex by using a Magstim Rapid magnetic stimulator. (Magstim Company, Whitland, UK) and 90 mm double cone coil.
Participants will proceed to 30 minute of treadmill training after rTMS. A safety harness without body weight support will be provided. 80% of participant's over ground maximum walking speed will be halved and used for warm-up. After warming up, walking speed will be increased by 0.2 km/h every 5 minutes. Progression will be given if patients could tolerate the belt speed with appropriate step length and walk with good stability for 5 minutes. Participants will maintain the maximum speed achieved for the rest of the session or adjusted as needed. Positive verbal feedback will be given to encourage large strides and upright posture during training. The participants will be instructed to walk on treadmill without holding onto the handrails if possible. Participants will perform warm up and cool down exercise to minimize training related-injury.
Fastest Walking Speed
Each participant is instructed to walk for 14 meters at their fastest walking speed for three trials. The time taken for the middle 10 meter was recorded. The average of three trials is used for analysis.
Time frame: Baseline, 1 day post-intervention, 1 month post-intervention, 3 month post-intervention
Timed-Up-and-Go Test (iTUG)
Participants are instructed to stand up from a chair and walk for 7 meters walkway and return back to the chair turn around and sit down. Time and gait parameters during TUG were captured by the valid and reliable APDM system, which is a wearable gait and balance analysis system.
Time frame: Baseline, 1 day post-intervention, 1 month post-intervention and 3 months post-intervention
the Motor Section of Movement Disorders Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS III)
MDS-UPDRS III is a valid and reliable clinical test, will be used to evaluate severity of motor symptoms of PD. There are total of 27 items including tremor, rigidity, bradykinesia, postural instability and gait performance. Each item scores from 0-4, with 0 indicates no disability and 4 maximum disabled with total score(s) ranges from 0 to 132.
Time frame: Baseline, I day post-intervention, 1 month post-intervention and 3 months post-intervention
Walking Distance in a 2 -Minute Walk Test
The 2 minute walk test will be conducted along a 20 m x 2 m hallway. A line is marked at each end of the walkway to indicate where the person is to turn. Participants will be instructed to " walk as far as possible in 2 minutes". They will be given standardised encouragement at 60 and 90 seconds during walk. Distance walked will be recorded to the nearest meter.
Time frame: Baseline, 1 day post-intervention, 1 month post-intervention and 3 months post-intervention
Mini Balance Evaluation Systems Test Scores
Balance performance of participants will be assessed in 4 domains namely anticipatory postural adjustments, postural responses, sensory orientation and gait stability. Each item is rated from 0-2 with a total scores of 28. The Total scores range from 0-28, with higher scores indicate better dynamic balance.
Time frame: Baseline, 1 day post-intervention, 1 month post-intervention and 3 months post-intervention
Dual-task Timed-Up-and-Go Test (DT-TUG)
For DT-TUG, participants were instructured to repeat the TUG procedure while performing a serial three substraction. Time taken to complete DT-TUG and accuracy of digital counting was recorded. One practice trial was given prior to both TUG and DT-TUG testing and average performance of three trials was used for analysis.
Time frame: Baseline, 1 day post-intervention, 1 month post-intervention, 3 month-post intervention
Cortical Silent Period
Ten suprathreshold TMS stimuli (i.e. 130% RMT) will be delivered while participant performing a 20% isometric maximal contraction of Tibialis Anterior of the more affected side. Cortical silent period (CSP) measures the duration of interruption of electromyography (EMG) activity in the contracting muscle produced by TMS. CSP duration will be determined as the period between the onset of MEP and the return of baseline EMG activity measured 50 ms before the TMS stimulus.
Time frame: Baseline, 1 day post-intervention, 1 month post-intervention and 3 months post-intervention
Gradient of the Recruitment Curve ( Also Known as Stimulus-response Curve)
TMS stimuli will be applied at 10% steps between 100% to 160% RMT. 10 stimuli will be delivered at each intensity. Peak to peak amplitude of 10 motor-evoked potentials (MEPs) at each stimulus intensity will be averaged offline.The cut-off intensity is set at 75% of maximum stimulator output due to discomfort perceived by majority of the participants. MEPs will be normalised with the maximal muscle action potential (MMax), which is determined by supramaximal electrical stimulation of the fibular nerve. A scatter graph will be generated with the average amplitude of MEPs as a function of stimulation intensity. The linear trend will be added to generate the linear recruitment curve slope.
Time frame: Baseline, 1 day post-intervention, 1 month post-intervention and 3 months post-intervention
Short-interval-intracortical Inhibition
Short-interval-intracortical inhibition (SICI) is another measure of cortical inhibition. In a paired- pulse TMS paradigm, a test pulse will be adjusted to produce MEP of at least 0.5 millivolts which will be delivered preceded by a brief conditioned pulse set at a lower intensity of 80% RMT with inter-stimulus interval of 2 milliseconds. Two stimulators connected via a Bistim module ( Magstim Co.,Whitland, UK) will be used in this test. Ten conditioned MEPs and unconditioned MEPs will be obtained in a random order and were averaged for each condition. SICI is expressed as percentage of unconditioned test MEP amplitude.
Time frame: Baseline, 1 day post-intervention, 1 month post-intervention and 3 months post-intervention
| Milestone | 25-Hz rTMS | 1-Hz rTMS | Sham rTMS |
|---|---|---|---|
| Started | 17 | 17 | 17 |
| Completed | 17 | 17 | 16 |
| Not completed | 0 | 0 | 1 |
Each participant is instructed to walk for 14 meters at their fastest walking speed for three trials. The time taken for the middle 10 meter was recorded. The average of three trials is used for analysis.
| cm/s | 25-Hz rTMS | 1-Hz rTMS | Sham rTMS |
|---|---|---|---|
| Baseline | 149.5 ± 24.7 | 153.1 ± 27.3 | 156.1 ± 30.2 |
| 1 day Post intervention | 164.3 ± 26.3 | 167.3 ± 34.0 | 160.7 ± 33.3 |
| 1 month post intervention | 167.8 ± 26.4 | 170.6 ± 35.6 | 164.6 ± 32.3 |
| 3 month post intervention | 163.2 ± 31.0 | 169.9 ± 38.7 | 156.7 ± 28.0 |
Participants are instructed to stand up from a chair and walk for 7 meters walkway and return back to the chair turn around and sit down. Time and gait parameters during TUG were captured by the valid and reliable APDM system, which is a wearable gait and balance analysis system.
| seconds | 25Hz-TT | 1Hz-TT | Sham-TT |
|---|---|---|---|
| Baseline | 20.8 ± 4.0 | 18.3 ± 2.5 | 19.3 ± 2.5 |
| 1 day Post intervention | 18.4 ± 2.8 | 17.1 ± 2.7 | 18.0 ± 2.1 |
| 1 month post intervention | 17.7 ± 2.9 | 17.1 ± 2.3 | 17.9 ± 1.8 |
| 3 month post intervention | 17.9 ± 2.8 | 16.6 ± 2.3 | 18.4 ± 2.1 |
MDS-UPDRS III is a valid and reliable clinical test, will be used to evaluate severity of motor symptoms of PD. There are total of 27 items including tremor, rigidity, bradykinesia, postural instability and gait performance. Each item scores from 0-4, with 0 indicates no disability and 4 maximum disabled with total score(s) ranges from 0 to 132.
| score on a scale | 25-Hz rTMS | 1-Hz rTMS | Sham rTMS |
|---|---|---|---|
| Baseline | 27.9 ± 10.5 | 27.1 ± 9.6 | 29.7 ± 10.6 |
| 1 day Post intervention | 19.9 ± 8.5 | 22.2 ± 7.5 | 27.9 ± 9.0 |
| 1 month post intervention | 20.8 ± 8.9 | 22.5 ± 7.3 | 27.9 ± 10.1 |
| 3 month post intervention | 22.5 ± 10.1 | 21.9 ± 7.8 | 27.3 ± 8.0 |
The 2 minute walk test will be conducted along a 20 m x 2 m hallway. A line is marked at each end of the walkway to indicate where the person is to turn. Participants will be instructed to " walk as far as possible in 2 minutes". They will be given standardised encouragement at 60 and 90 seconds during walk. Distance walked will be recorded to the nearest meter.
| meter | 25Hz-TT | 1Hz-TT | Sham-TT |
|---|---|---|---|
| Baseline | 147.4 ± 29.8 | 144.7 ± 31.3 | 148.7 ± 25.0 |
| 1 day post intervention | 160.4 ± 28.0 | 164.9 ± 29.8 | 157.3 ± 31.7 |
| 1 month post intervention | 166.3 ± 29.7 | 167.9 ± 29.7 | 157.9 ± 29.7 |
| 3 month post intervention | 163.1 ± 30.7 | 166.8 ± 31.2 | 160.5 ± 28.9 |
Balance performance of participants will be assessed in 4 domains namely anticipatory postural adjustments, postural responses, sensory orientation and gait stability. Each item is rated from 0-2 with a total scores of 28. The Total scores range from 0-28, with higher scores indicate better dynamic balance.
| score on a scale | 25Hz-TT | 1Hz-TT | Sham-TT |
|---|---|---|---|
| Baseline | 21.5 ± 3.4 | 21.8 ± 2.7 | 21.7 ± 2.8 |
| 1 day post intervention | 24.2 ± 2.5 | 23.8 ± 2.7 | 22.4 ± 2.2 |
| 1 month post intervention | 23.8 ± 2.8 | 23.5 ± 2.5 | 22.8 ± 2.5 |
| 3 month post intervention | 23.4 ± 3.0 | 24.1 ± 2.6 | 23.0 ± 2.4 |
For DT-TUG, participants were instructured to repeat the TUG procedure while performing a serial three substraction. Time taken to complete DT-TUG and accuracy of digital counting was recorded. One practice trial was given prior to both TUG and DT-TUG testing and average performance of three trials was used for analysis.
| seconds | 25-Hz rTMS | 1-Hz rTMS | Sham rTMS |
|---|---|---|---|
| Baseline | 27.9 ± 8.8 | 24.0 ± 7.0 | 25.5 ± 5.6 |
| 1 day Post intervention | 23.1 ± 5.6 | 21.1 ± 5.2 | 23.4 ± 4.0 |
| 1 month post intervention | 21.8 ± 6.0 | 20.6 ± 4.7 | 23.9 ± 3.9 |
| 3 month post intervention | 22.3 ± 6.0 | 20.3 ± 4.6 | 23.9 ± 3.9 |
Ten suprathreshold TMS stimuli (i.e. 130% RMT) will be delivered while participant performing a 20% isometric maximal contraction of Tibialis Anterior of the more affected side. Cortical silent period (CSP) measures the duration of interruption of electromyography (EMG) activity in the contracting muscle produced by TMS. CSP duration will be determined as the period between the onset of MEP and the return of baseline EMG activity measured 50 ms before the TMS stimulus.
| milliseconds | 25-Hz rTMS | 1-Hz rTMS | Sham rTMS |
|---|---|---|---|
| Baseline | 176.5 ± 50.0 | 164.6 ± 39.8 | 183.9 ± 38.9 |
| 1 day Post intervention | 194.4 ± 53.2 | 180.6 ± 39.1 | 175.1 ± 46.6 |
| 1 month post intervention | 190.1 ± 54.5 | 160.1 ± 41.1 | 189.2 ± 37.6 |
| 3 month post intervention | 175.9 ± 43.2 | 154.6 ± 46.0 | 182.9 ± 35.0 |
TMS stimuli will be applied at 10% steps between 100% to 160% RMT. 10 stimuli will be delivered at each intensity. Peak to peak amplitude of 10 motor-evoked potentials (MEPs) at each stimulus intensity will be averaged offline.The cut-off intensity is set at 75% of maximum stimulator output due to discomfort perceived by majority of the participants. MEPs will be normalised with the maximal muscle action potential (MMax), which is determined by supramaximal electrical stimulation of the fibular nerve. A scatter graph will be generated with the average amplitude of MEPs as a function of stimulation intensity. The linear trend will be added to generate the linear recruitment curve slope.
| millivolts / % maximum stimulator output | 25-Hz rTMS | 1-Hz rTMS | Sham rTMS |
|---|---|---|---|
| Baseline | 0.51 ± 0.30 | 0.53 ± 0.39 | 0.61 ± 0.32 |
| 1 day Post intervention | 0.58 ± 0.36 | 0.64 ± 0.37 | 0.52 ± 0.40 |
| 1 month post intervention | 0.70 ± 0.57 | 0.63 ± 0.30 | 0.59 ± 0.43 |
| 3 month post intervention | 0.74 ± 0.47 | 0.70 ± 0.41 | 0.58 ± 0.45 |
Short-interval-intracortical inhibition (SICI) is another measure of cortical inhibition. In a paired- pulse TMS paradigm, a test pulse will be adjusted to produce MEP of at least 0.5 millivolts which will be delivered preceded by a brief conditioned pulse set at a lower intensity of 80% RMT with inter-stimulus interval of 2 milliseconds. Two stimulators connected via a Bistim module ( Magstim Co.,Whitland, UK) will be used in this test. Ten conditioned MEPs and unconditioned MEPs will be obtained in a random order and were averaged for each condition. SICI is expressed as percentage of unconditioned test MEP amplitude.
| percentage of Unconditioned MEPs | 25-Hz rTMS | 1-Hz rTMS | Sham rTMS |
|---|---|---|---|
| Baseline | 56.4 ± 27.0 | 49.4 ± 24.1 | 62.2 ± 33.1 |
| 1 day Post intervention | 44.4 ± 23.0 | 51.4 ± 28.2 | 76.5 ± 49.8 |
| 1 month post intervention | 42.0 ± 26.9 | 62.6 ± 31.7 | 89.8 ± 62.9 |
| 3 month post intervention | 50.8 ± 22.8 | 60.7 ± 39.2 | 74.3 ± 30.2 |
Collected over during intervention, at 1 day post-intervention,1 month post-intervention and at 3 month post-intervention. Non-serious events are listed at a 0% frequency threshold.
| Group | Deaths | Serious | Other |
|---|---|---|---|
| 25-Hz rTMS | 0/17 (0%) | 0/17 (0%) | 0/17 (0%) |
| 1-Hz rTMS | 0/17 (0%) | 0/17 (0%) | 0/17 (0%) |
| Sham rTMS | 0/16 (0%) | 0/16 (0%) | 0/16 (0%) |
| Age, Categorical(Participants) | 25-Hz rTMS | 1-Hz rTMS | Sham rTMS | Total |
|---|---|---|---|---|
| <=18 years | 0 | 0 | 0 | 0 |
| Between 18 and 65 years | 13 | 11 | 11 | 35 |
| >=65 years | 4 | 6 | 5 | 15 |
| Age, Continuous(years) | 25-Hz rTMS | 1-Hz rTMS | Sham rTMS | Total |
|---|---|---|---|---|
| Mean | 62.7 ± 6.8 | 62.1 ± 5.7 | 62.1 ± 5.7 | 62.3 ± 6.0 |
| Sex: Female, Male(Participants) | 25-Hz rTMS | 1-Hz rTMS | Sham rTMS | Total |
|---|---|---|---|---|
| Female | 7 | 8 | 9 | 24 |
| Male | 10 | 9 | 7 | 26 |
| Race and Ethnicity Not Collected(Participants) | 25-Hz rTMS | 1-Hz rTMS | Sham rTMS | Total |
|---|---|---|---|---|
| Count of participants | — | — | — | 0 |
| Region of Enrollment(participants) | 25-Hz rTMS | 1-Hz rTMS | Sham rTMS | Total |
|---|---|---|---|---|
| Hong Kong | 17 | 17 | 16 | 50 |
| Disease duration (no. of years of diagnosis of PD)(years) | 25-Hz rTMS | 1-Hz rTMS | Sham rTMS | Total |
|---|---|---|---|---|
| Mean | 5.2 ± 3.4 | 7.5 ± 4.9 | 6.9 ± 3.3 | 6.5 ± 4.0 |
| daily levodopa equivalent dose(mg/day) | 25-Hz rTMS | 1-Hz rTMS | Sham rTMS | Total |
|---|---|---|---|---|
| Mean | 484.2 ± 336.4 | 512.5 ± 359.9 | 493.3 ± 523.9 | 496.8 ± 404.2 |
Documents are hosted by the registry — open the source record to download them.
Plan to share: Yes — Data will be shared with researcher who provide a methodologically sound proposal
Supporting information: Study protocol, Statistical analysis plan, Informed consent form
Time frame: Beginning 3 months and ending 3 years following article publication
Access criteria: request through email
This study is completed, as verified in Jun 2018. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
The Hong Kong Polytechnic University →